Selected research
Industry Growth & Trends
Global Clinical Trials Outsourcing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Clinical Trials Outsourcing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Clinical Trials Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Clinical Trials Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Clinical Trials Outsourcing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Clinical Trials Outsourcing market include Charles River Laboratories, IQVIA, ICON PLC, Labcorp Drug Development, Syneos Health, Thermo Fisher Scientific, Wuxi AppTec, Parexel and Advanced Clinical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Clinical Trials Outsourcing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Clinical Trials Outsourcing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Clinical Trials Outsourcing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Clinical Trials Outsourcing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Clinical Trials Outsourcing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Clinical Trials Outsourcing Market by Company
Charles River Laboratories
IQVIA
ICON PLC
Labcorp Drug Development
Syneos Health
Thermo Fisher Scientific
Wuxi AppTec
Parexel
Advanced Clinical
BioAnalytix
Curia Global
CMED
Cromos Pharma
Criterium
KCR S.A.
Medpace
Medelis
OCT Group
ProTrials Research
PROMETRIKA
Quality Data Service
QPS
Sofpromed
Veristat
Worldwide Clinical Trials
Clinical Trials Outsourcing Segment by Type
Phase I
Phase II
Phase III
Phase IV
Clinical Trials Outsourcing Segment by Application
Cancer
CVDs
Infectious Diseases
Musculoskeletal Diseases
Nervous System Disorders
Others
Clinical Trials Outsourcing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Trials Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Trials Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Trials Outsourcing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Clinical Trials Outsourcing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Phase I
- Phase II
- Phase III
- Phase IV
Applications
- Cancer
- CVDs
- Infectious Diseases
- Musculoskeletal Diseases
- Nervous System Disorders
- Others
Companies covered
- Charles River Laboratories
- IQVIA
- ICON PLC
- Labcorp Drug Development
- Syneos Health
- Thermo Fisher Scientific
- Wuxi AppTec
- Parexel
- Advanced Clinical
- BioAnalytix
- Curia Global
- CMED
- Cromos Pharma
- Criterium
- KCR S.A.
- Medpace
- Medelis
- OCT Group
- ProTrials Research
- PROMETRIKA
- Quality Data Service
- QPS
- Sofpromed
- Veristat
- Worldwide Clinical Trials
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Clinical Trials Outsourcing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Clinical Trials Outsourcing Market Size by Region (2021-2032)
- 1.4.1 Global Clinical Trials Outsourcing Market Size by Region (2021-2026)
- 1.4.2 Global Clinical Trials Outsourcing Market Size by Region (2027-2032)
- 1.5 Key Regions Clinical Trials Outsourcing Market Size (2021-2032)
- 1.5.1 North America Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Clinical Trials Outsourcing Market Size Growth Rate (2021-2032)
2 Clinical Trials Outsourcing Market by Type
- 2.1 Type Introduction
- 2.1.1 Phase I
- 2.1.2 Phase II
- 2.1.3 Phase III
- 2.1.4 Phase IV
- 2.2 Global Clinical Trials Outsourcing Market Size by Type
- 2.2.1 Global Clinical Trials Outsourcing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Clinical Trials Outsourcing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Clinical Trials Outsourcing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Clinical Trials Outsourcing Market Size by Regions
- 2.3.1 North America Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Clinical Trials Outsourcing Market Size Breakdown by Type (2021-2026)
3 Clinical Trials Outsourcing Market by Application
- 3.1 Type Introduction
- 3.1.1 Cancer
- 3.1.2 CVDs
- 3.1.3 Infectious Diseases
- 3.1.4 Musculoskeletal Diseases
- 3.1.5 Nervous System Disorders
- 3.1.6 Others
- 3.2 Global Clinical Trials Outsourcing Market Size by Application
- 3.2.1 Global Clinical Trials Outsourcing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Clinical Trials Outsourcing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Clinical Trials Outsourcing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Clinical Trials Outsourcing Market Size by Regions
- 3.3.1 North America Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Clinical Trials Outsourcing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Clinical Trials Outsourcing Industry Trends
- 4.2 Clinical Trials Outsourcing Industry Drivers
- 4.3 Clinical Trials Outsourcing Industry Opportunities and Challenges
- 4.4 Clinical Trials Outsourcing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Clinical Trials Outsourcing Revenue (2021-2026)
- 5.2 Global Clinical Trials Outsourcing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Clinical Trials Outsourcing Key Company Headquarters & Area Served
- 5.4 Global Clinical Trials Outsourcing Company, Product Type & Application
- 5.5 Global Clinical Trials Outsourcing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Clinical Trials Outsourcing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Clinical Trials Outsourcing Players Market Share by Revenue in 2025
- 5.6.3 2025 Clinical Trials Outsourcing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Charles River Laboratories
- 6.1.1 Charles River Laboratories Company Information
- 6.1.2 Charles River Laboratories Business Overview
- 6.1.3 Charles River Laboratories Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Charles River Laboratories Clinical Trials Outsourcing Product Portfolio
- 6.1.5 Charles River Laboratories Recent Developments
- 6.2 IQVIA
- 6.2.1 IQVIA Company Information
- 6.2.2 IQVIA Business Overview
- 6.2.3 IQVIA Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 IQVIA Clinical Trials Outsourcing Product Portfolio
- 6.2.5 IQVIA Recent Developments
- 6.3 ICON PLC
- 6.3.1 ICON PLC Company Information
- 6.3.2 ICON PLC Business Overview
- 6.3.3 ICON PLC Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 ICON PLC Clinical Trials Outsourcing Product Portfolio
- 6.3.5 ICON PLC Recent Developments
- 6.4 Labcorp Drug Development
- 6.4.1 Labcorp Drug Development Company Information
- 6.4.2 Labcorp Drug Development Business Overview
- 6.4.3 Labcorp Drug Development Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Labcorp Drug Development Clinical Trials Outsourcing Product Portfolio
- 6.4.5 Labcorp Drug Development Recent Developments
- 6.5 Syneos Health
- 6.5.1 Syneos Health Company Information
- 6.5.2 Syneos Health Business Overview
- 6.5.3 Syneos Health Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Syneos Health Clinical Trials Outsourcing Product Portfolio
- 6.5.5 Syneos Health Recent Developments
- 6.6 Thermo Fisher Scientific
- 6.6.1 Thermo Fisher Scientific Company Information
- 6.6.2 Thermo Fisher Scientific Business Overview
- 6.6.3 Thermo Fisher Scientific Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Thermo Fisher Scientific Clinical Trials Outsourcing Product Portfolio
- 6.6.5 Thermo Fisher Scientific Recent Developments
- 6.7 Wuxi AppTec
- 6.7.1 Wuxi AppTec Company Information
- 6.7.2 Wuxi AppTec Business Overview
- 6.7.3 Wuxi AppTec Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Wuxi AppTec Clinical Trials Outsourcing Product Portfolio
- 6.7.5 Wuxi AppTec Recent Developments
- 6.8 Parexel
- 6.8.1 Parexel Company Information
- 6.8.2 Parexel Business Overview
- 6.8.3 Parexel Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Parexel Clinical Trials Outsourcing Product Portfolio
- 6.8.5 Parexel Recent Developments
- 6.9 Advanced Clinical
- 6.9.1 Advanced Clinical Company Information
- 6.9.2 Advanced Clinical Business Overview
- 6.9.3 Advanced Clinical Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Advanced Clinical Clinical Trials Outsourcing Product Portfolio
- 6.9.5 Advanced Clinical Recent Developments
- 6.10 BioAnalytix
- 6.10.1 BioAnalytix Company Information
- 6.10.2 BioAnalytix Business Overview
- 6.10.3 BioAnalytix Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 BioAnalytix Clinical Trials Outsourcing Product Portfolio
- 6.10.5 BioAnalytix Recent Developments
- 6.11 Curia Global
- 6.11.1 Curia Global Company Information
- 6.11.2 Curia Global Business Overview
- 6.11.3 Curia Global Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Curia Global Clinical Trials Outsourcing Product Portfolio
- 6.11.5 Curia Global Recent Developments
- 6.12 CMED
- 6.12.1 CMED Company Information
- 6.12.2 CMED Business Overview
- 6.12.3 CMED Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 CMED Clinical Trials Outsourcing Product Portfolio
- 6.12.5 CMED Recent Developments
- 6.13 Cromos Pharma
- 6.13.1 Cromos Pharma Company Information
- 6.13.2 Cromos Pharma Business Overview
- 6.13.3 Cromos Pharma Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Cromos Pharma Clinical Trials Outsourcing Product Portfolio
- 6.13.5 Cromos Pharma Recent Developments
- 6.14 Criterium
- 6.14.1 Criterium Company Information
- 6.14.2 Criterium Business Overview
- 6.14.3 Criterium Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Criterium Clinical Trials Outsourcing Product Portfolio
- 6.14.5 Criterium Recent Developments
- 6.15 KCR S.A.
- 6.15.1 KCR S.A. Company Information
- 6.15.2 KCR S.A. Business Overview
- 6.15.3 KCR S.A. Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 KCR S.A. Clinical Trials Outsourcing Product Portfolio
- 6.15.5 KCR S.A. Recent Developments
- 6.16 Medpace
- 6.16.1 Medpace Company Information
- 6.16.2 Medpace Business Overview
- 6.16.3 Medpace Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Medpace Clinical Trials Outsourcing Product Portfolio
- 6.16.5 Medpace Recent Developments
- 6.17 Medelis
- 6.17.1 Medelis Company Information
- 6.17.2 Medelis Business Overview
- 6.17.3 Medelis Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Medelis Clinical Trials Outsourcing Product Portfolio
- 6.17.5 Medelis Recent Developments
- 6.18 OCT Group
- 6.18.1 OCT Group Company Information
- 6.18.2 OCT Group Business Overview
- 6.18.3 OCT Group Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 OCT Group Clinical Trials Outsourcing Product Portfolio
- 6.18.5 OCT Group Recent Developments
- 6.19 ProTrials Research
- 6.19.1 ProTrials Research Company Information
- 6.19.2 ProTrials Research Business Overview
- 6.19.3 ProTrials Research Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 ProTrials Research Clinical Trials Outsourcing Product Portfolio
- 6.19.5 ProTrials Research Recent Developments
- 6.20 PROMETRIKA
- 6.20.1 PROMETRIKA Company Information
- 6.20.2 PROMETRIKA Business Overview
- 6.20.3 PROMETRIKA Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 PROMETRIKA Clinical Trials Outsourcing Product Portfolio
- 6.20.5 PROMETRIKA Recent Developments
- 6.21 Quality Data Service
- 6.21.1 Quality Data Service Company Information
- 6.21.2 Quality Data Service Business Overview
- 6.21.3 Quality Data Service Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Quality Data Service Clinical Trials Outsourcing Product Portfolio
- 6.21.5 Quality Data Service Recent Developments
- 6.22 QPS
- 6.22.1 QPS Company Information
- 6.22.2 QPS Business Overview
- 6.22.3 QPS Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.22.4 QPS Clinical Trials Outsourcing Product Portfolio
- 6.22.5 QPS Recent Developments
- 6.23 Sofpromed
- 6.23.1 Sofpromed Company Information
- 6.23.2 Sofpromed Business Overview
- 6.23.3 Sofpromed Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.23.4 Sofpromed Clinical Trials Outsourcing Product Portfolio
- 6.23.5 Sofpromed Recent Developments
- 6.24 Veristat
- 6.24.1 Veristat Company Information
- 6.24.2 Veristat Business Overview
- 6.24.3 Veristat Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.24.4 Veristat Clinical Trials Outsourcing Product Portfolio
- 6.24.5 Veristat Recent Developments
- 6.25 Worldwide Clinical Trials
- 6.25.1 Worldwide Clinical Trials Company Information
- 6.25.2 Worldwide Clinical Trials Business Overview
- 6.25.3 Worldwide Clinical Trials Clinical Trials Outsourcing Revenue, Global Share and Gross Margin (2021-2026)
- 6.25.4 Worldwide Clinical Trials Clinical Trials Outsourcing Product Portfolio
- 6.25.5 Worldwide Clinical Trials Recent Developments
7 North America
- 7.1 North America Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 7.3 North America Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 8.3 Europe Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 10.3 South America Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Trials Outsourcing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Clinical Trials Outsourcing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Clinical Trials Outsourcing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst